1. Strong Q3 FY26 Results (Quarter Ended Dec 31, 2025) Apollo Hospitals reported robust financial numbers earlier this week, driven by broad-based growth across its hospital, pharmacy, and diagnostic segments. Net Profit: ₹502 Crore, a jump of 35% YoY (up from ₹372 Crore in Q3 FY25). Revenue: ₹6,477 Crore, up 17% YoY. Operational Highlights: EBITDA grew 27% to ₹965 Crore, with margins expanding to 14.9%. Healthcare Services (Hospitals): Revenue grew 14%, supported by higher occupancy and a better case mix (more complex surgeries). Apollo HealthCo (Digital & Pharmacy): Revenue rose 20% to ₹2,827 Crore, with significant profitability improvement (EBITDA more than doubled to ₹128 Crore). 2. Corporate Action: Interim Dividend Dividend Declared: The Board approved an interim dividend of ₹10 per equity share (200% of face value). Record Date: Monday, February 16, 2026 (Tomorrow). If you hold the stock by the end of tomorrow, you are eligible. Payment Date: The dividend will be paid on or before February 27, 2026.